Immunomodulatory Effects of Lactobacillus plantarum Lp62 on Intestinal Epithelial and Mononuclear Cells

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Ferreira Dos Santos, Thalis ^a   Alves Melo, Tauá ^b   Almeida, Milena Evangelista ^b   Passos Rezende, Rachel ^b   Romano, Carla Cristina ^b  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CD4+ CD25+ T LYMPHOCYTE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; LACTOBACILLUS PLANTARUM; LACTOBACILLUS PLANTARUM LP62; LEUKOCYTE CULTURE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SALMONELLA ENTERICA SEROVAR TYPHI; ANIMAL; BIOSYNTHESIS; CELL LINE; HT-29 CELL LINE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY; MOUSE; PROCEDURES; REGULATORY T LYMPHOCYTE;

ANIMALS; CELL LINE; GASTROINTESTINAL MICROBIOME; HT29 CELLS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTESTINAL MUCOSA; LACTOBACILLUS PLANTARUM; MACROPHAGES; MICE; PROBIOTICS; T-LYMPHOCYTES, REGULATORY;

EID: 84982821514     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/8404156     Document Type: Article

References (30)

1. L. M. T. Dicks and M. Botes, "Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action, " Beneficial Microbes, vol. 1, no. 1, pp. 11-29, 2010.
2. S. Fijan, "Microorganisms with claimed probiotic properties: an overview of recent literature, " International Journal of Environmental Research and Public Health, vol. 11, no. 5, pp. 4745-4767, 2014.
3. C. Hill, F. Guarner, G. Reid et al., "Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the termprobiotic, " Nature Reviews Gastroenterology and Hepatology, vol. 11, no. 8, pp. 506-514, 2014.
4. R. Bringiotti, R. Lerardi, R. Lovero, G. Losurdo, A. Di Leo, and M. Principi, "Intestinal microbiota: the explosive mixture at the origin of inflammatory bowel disease?" World Journal of Gastrointestinal Pathophysiology, vol. 5, no. 4, pp. 550-559, 2014.
5. J. Plaza-Diaz, C. Gomez-Llorente, L. Fontana, and A. Gil, "Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics, "World Journal of Gastroenterology, vol. 20, no. 42, pp. 15632-15649, 2014.
6. R. J. Siezen and J. E. T. Vlieg, "Genomic diversity and versatility of Lactobacillus plantarum, a natural metabolic engineer, " Microbial Cell Factories, vol. 10, no. 1, article S3, 2011.
7. C. Bäuerl, M. Llopis, M. Antolín et al., "Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa, " Genes & Nutrition, vol. 8, no. 2, pp. 165-180, 2013.
8. S. Rokka, A. Pihlanto, H. Korhonen, and V. Joutsjoki, "In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group, " Letters in Applied Microbiology, vol. 43, no. 5, pp. 508-513, 2006.
9. P. Ducrotté, P. Sawant, and V. Jayanthi, "Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome, " World Journal of Gastoenterology, vol. 18, no. 30, pp. 4012-4018, 2012.
10. R. K. Duary, M. A. Bhausaheb, V. K. Batish, and S. Grover, "Antiinflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitismouse model, " Molecular Biology Reports, vol. 39, no. 4, pp. 4765-4775, 2012.
11. M. J. Smelt, B. J. de Haan, P. A. Bron et al., "The Impact of Lactobacillus plantarum WCFS1 teichoic acid D-alanylation on the generation of effector and regulatory T-cells in healthy mice, " PLoS ONE, vol. 8, no. 4, article e63099, 2013.
12. T. F. Dos Santos, Probiotic potential of lactic acid bacteria isolated from cocoa beans fermentation in southern Bahia, Brazil [M. S. thesis], Santa Cruz State University, Biology Department, 2010, http://www. dominiopublico. gov. br/pesquisa/DetalheObra-Form. do?select action=&co obra=187827.
13. M. Z. Cader and A. Kaser, "Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation, " Gut, vol. 62, no. 11, pp. 1653-1664, 2013.
14. C. Banks, A. Bateman, R. Payne, P. Johnson, and N. Sheron, "Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease, " Journal of Pathology, vol. 199, no. 1, pp. 28-35, 2003.
15. D.-Y. Ren, C. Li, Y.-Q. Qin et al., "Lactobacilli reduce chemokine IL-8 production in response to TNF-and Salmonella challenge of caco-2 cells, " BioMed Research International, vol. 2013, Article ID 925219, 9 pages, 2013.
16. C. M. Carey and M. Kostrzynska, "Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by salmonella enterica serovar typhimurium, " Canadian Journal of Microbiology, vol. 59, no. 1, pp. 9-17, 2013.
17. J. G. Magalhaes, I. Tattoli, and S. E. Girardin, "The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens, " Seminars in Immunology, vol. 19, no. 2, pp. 106-115, 2007.
18. H. Karlsson, C. Hessle, and A. Rudin, "Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora, " Infection and Immunity, vol. 70, no. 12, pp. 6688-6696, 2002.
19. M. Schenk andC. Mueller, "Adaptations of intestinalmacrophages to an antigen-rich environment, " Seminars in Immunology, vol. 19, no. 2, pp. 84-93, 2007.
20. J. Rugtveit, A. Bakka, and P. Brandtzaeg, "Differential distribution of B7. 1 (CD80) and B7. 2 (CD86) costimulatory molecules onmucosalmacrophage subsets in human inflammatory bowel disease (IBD), " Clinical and Experimental Immunology, vol. 110, no. 1, pp. 104-113, 1997.
21. M. Hausmann, S. Kiessling, S. Mestermann et al., "Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation, " Gastroenterology, vol. 122, no. 7, pp. 1987-2000, 2002.
22. S. Pathmakanthan, C. K. F. Li, J. Cowie, and C. J. Hawkey, "Lactobacillus plantarum 299v: beneficial in vitro immunomodulation in cells extracted from inflamed human colon, " Journal of Gastroenterology and Hepatology, vol. 19, no. 2, pp. 166-173, 2004.
23. J. A. Peña and J. Versalovic, "Lactobacillus rhamnosus GG decreases TNF-production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism, " Cellular Microbiology, vol. 5, no. 4, pp. 277-285, 2003.
24. M. Matsumoto and Y. Benno, "Anti-inflammatory metabolite production in the gut from the consumption of probiotic yogurt containing Bifidobacterium animalis subsp. lactis LKM512, " Bioscience, Biotechnology and Biochemistry, vol. 70, no. 6, pp. 1287-1292, 2006.
25. S. Latvala, T. E. Pietilä, V. Veckman et al., "Potentially probiotic bacteria induce efficient maturation but differential cytokine production in humanmonocyte-derived dendritic cells, " World Journal of Gastroenterology, vol. 14, no. 36, pp. 5570-5583, 2008.
26. A. Geremia, P. Biancheri, P. Allan, G. R. Corazza, and A. Di Sabatino, "Innate and adaptive immunity in inflammatory bowel disease, " Autoimmunity Reviews, vol. 13, no. 1, pp. 3-10, 2014.
27. J. L. Coombes and K. J. Maloy, "Control of intestinal homeostasis by regulatory T cells and dendritic cells, " Seminars in Immunology, vol. 19, no. 2, pp. 116-126, 2007.
28. H. Dong, I. Rowland, L. V. Thomas, and P. Yaqoob, "Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers, " European Journal of Nutrition, vol. 52, no. 8, pp. 1853-1863, 2013.
29. S. Sierra, F. Lara-Villoslada, L. Sempere, M. Olivares, J. Boza, and J. Xaus, "Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults, " Anaerobe, vol. 16, no. 3, pp. 195-200, 2010.
30. J. Mañé, E. Pedrosa, V. Lorén et al., "A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial, " Nutricion Hospitalaria, vol. 26, no. 1, pp. 228-235, 2011.